Maurice C. van Staveren

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study

Mirjam de With, Jonathan E. Knikman, Femke M. de Man et al. · Clinical Pharmacology & Therapeutics · 2022 · 56 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +14

Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency

Maurice C. van Staveren, Barbara N Theeuwes-Oonk, Henk‐Jan Guchelaar et al. · Cancer Chemotherapy and Pharmacology · 2011 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +7

Evaluation of an oral uracil loading test to identify DPD‐deficient patients using a limited sampling strategy

Maurice C. van Staveren, André B. P. Kuilenburg, Henk‐Jan Guchelaar et al. · British Journal of Clinical Pharmacology · 2015 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Evaluation of Clinical Implementation of Prospective <i>DPYD</i> Genotyping in 5-Fluorouracil- or Capecitabine-Treated Patients

Carin ATC Lunenburg, Maurice C. van Staveren, Hans Gelderblom et al. · Pharmacogenomics · 2016 · 30 citations

Medicine, Oncology, Pharmacology +17